Skip to main content
Medicover logo

Medicover — Investor Relations & Filings

Ticker · MCOV ISIN · SE0009778848 LEI · 5493000E9BUOYMOW2K53 ST Human health and social work activities
Open in API
Filings indexed 285 across all filing types
Latest filing 2019-05-10 M&A Activity
Country SE Sweden
Listing ST MCOV

About Medicover

https://www.medicover.com/

Medicover is an international healthcare and diagnostic services provider. The company operates through two main divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division delivers a broad range of medical care, including primary care, specialist consultations, and hospital treatment. The Diagnostic Services division offers a comprehensive array of laboratory tests, from routine to advanced diagnostics, serving a wide network of clients. Committed to patient-centric care, Medicover focuses on quality, accessibility, and affordability by investing in modern medical technology and innovation. Its core mission is to improve and sustain the health and wellbeing of its customers.

Recent filings

Filing Released Lang Actions
Förvärvet av Neomedic slutfört
M&A Activity Classification · 1% confidence The document is a press release (Pressmeddelande) dated May 10, 2019, announcing the completion of an acquisition ('FÖRVÄRVET AV NEOMEDIC SLUTFÖRT'). It details the acquired entity, the purchase price (€70.5 million), financing methods, and expected financial impact. This type of announcement, detailing a significant corporate transaction like an acquisition or takeover bid, aligns directly with the definition for M&A Activity (TAR). It is not an Earnings Release (ER) as it focuses on a transaction, not periodic financial results. It is not a general Regulatory Filing (RNS) because it fits the specific M&A category (TAR). The document length is short, but it is the primary announcement of the transaction itself, not an announcement *about* a report.
2019-05-10 Swedish
Kommuniké från årsstämma i Medicover AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "KOMMUNIKÉ FRÅN ÅRSSTÄMMA I MEDICOVER AB (PUBL)" which translates to "COMMUNIQUÉ FROM THE ANNUAL GENERAL MEETING OF MEDICOVER AB (PUBL)". It details the resolutions passed regarding the election of the board, auditor fees, approval of the 2018 annual report, dividend decision (none), approval of remuneration guidelines, and adoption of a long-term incentive plan. These are all standard items discussed and resolved at an Annual General Meeting (AGM). Therefore, the correct classification is AGM Information (AGM-R). The document is a summary/press release of the meeting outcomes, not the full presentation materials, but it directly relates to the AGM proceedings.
2019-05-03 Swedish
Bulletin from annual general meeting in Medicover AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled 'BULLETIN FROM ANNUAL GENERAL MEETING IN MEDICOVER AB (PUBL)' and details resolutions passed at the AGM held on May 3, 2019. It covers the election of the board, auditor fees, adoption of annual accounts, dividend decisions, approval of remuneration guidelines, and authorizations for share programs and issuance. This content directly corresponds to the materials presented or decided upon during an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2019-05-03 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–March 2019 for Medicover. It contains detailed financial statements, including income statements, segment reporting (Healthcare Services and Diagnostic Services), and management commentary on financial performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-03 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT JANUARY–MARCH 2019' and contains detailed financial statements, including revenue, operating profit, EBITDA, and earnings per share for the first quarter. It provides a comprehensive analysis of business segments (Healthcare Services and Diagnostic Services), CEO commentary, and comparative tables for Q1 2019 vs Q1 2018. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2019
2019-05-03 English
Antal aktier och röster i Medicover
Share Issue/Capital Change Classification · 1% confidence The document is a press release dated April 30, 2019, titled "ANTAL AKTIER OCH RÖSTER I MEDICOVER" (Number of Shares and Votes in Medicover). It details a change in the total number of shares and the corresponding voting rights following the conversion of A-shares to B-shares. This type of announcement, which reports on changes in the capital structure (specifically voting rights tied to share classes), aligns most closely with the definition of a Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Since it specifically details the current share count and voting rights after a structural change (conversion), CAP is a strong fit. However, given the nature of reporting share structure changes, it also relates to shareholder structure. Reviewing the definitions, 'SHA' is for Share Issue/Capital Change, which covers changes in capital structure. 'CAP' is for fundraising/financing activities. Since this is a notification about the existing capital structure's voting rights post-conversion, it is a change in capital structure. If 'SHA' is interpreted strictly as new issuance or splits, 'CAP' might be considered, but 'SHA' (Share Issue/Capital Change) is the most precise fit for reporting the final count of shares and votes following a conversion event, which alters the capital structure. Given the options, and focusing on the change in the number of shares and votes, SHA is the best fit, although it is a very specific type of capital change announcement. If it were purely a general regulatory update without specific financial structure detail, RNS would apply. Since it is a precise update on the share count and voting rights, SHA is selected.
2019-04-30 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.